As such, we speculate that OC-derived RANKL may modulate the tumour microenvironment and particularly tumour immune responses [7] which could involve stromal cells or infiltrating immune cells and an inflammatory OC environment [34,35,36]. The gene discussed is TNFSF11; the disease is neoplasm.